“Specialty”

23 result(s)
Specialty
7 Stats That Show What Providers Think About Biosimilars
7 stats that show what providers think about biosimilars More
Briefing
Specialty
Advancing Our Clinical Agenda
Advancing Caremark’s clinical agenda through population health More
Commentary
Cost Management
Connected in Care: A Proactive Approach to Managing Specialty Drugs
Lowering specialty costs through ongoing engagement with members More
Briefing
2023 Forum
Drug Pipeline
The Dynamic Biosimilars Market
The Dynamic Biosimilars Market More
Video
Specialty
How Digital Connectivity Improves the Patient Experience
CVS Health leader discusses the value of being connected in care to patients and providers More
Briefing
Specialty
Member Education: How We Help Build Awareness
Supporting members through prescription changes with CVS Health’s many touchpoints, expertise, and data More
Briefing
Drug Pipeline
Biosimilars in the Autoimmune Category
Biosimilars in the Autoimmune Category More
Briefing
Specialty
The First Biosimilar to Humira Is Here. Now What?
The First Biosimilar to Humira Is Here More
Briefing
Health Equity
Marketplace Trends Shape Specialty Landscape
... More
Briefing
Care Management
Keeping Member Access to Medication Safe from the Storm
... More
Briefing